Cardiogenomics Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Cardiogenomics Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The cardiogenomics market size has experienced significant expansion recently. It is anticipated to increase from $1.50 billion in 2024 to $1.74 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 15.8%. This historical growth can be attributed to factors such as the increasing utilization of polygenic risk scores in cardiac care, a rise in investments dedicated to genomic research and development, increased government and private funding directed towards cardiovascular genomics, a growing inclination towards preventive cardiology via genetic insights, and an enhanced focus on population-scale genomic studies.

The cardiogenomics market size is projected to see significant expansion over the next few years, anticipated to reach $3.10 billion by 2029, growing at a compound annual growth rate (CAGR) of 15.5%. This growth during the forecast period is primarily driven by the increasing demand for personalized medicine, the rising prevalence of cardiovascular diseases, greater adoption of genetic testing for early risk detection, a growing awareness of precision medicine approaches, and the increasing availability of direct-to-consumer genetic testing services. Key trends expected in this period include technological innovations in sequencing that enable precise cardiac analysis, the integration of genomics with health records to support personalized care, developments in polygenic risk scoring to improve early disease prediction, advancements in bioinformatics accelerating genomic data interpretation, and the emergence of technology platforms enabling high-throughput genetic testing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28156&type=smp

Which Factors And Drivers Are Influencing The Cardiogenomics Market In 2025?

The future expansion of the cardiogenomics market is anticipated to be driven by the growing need for personalized medicine. Personalized medicine represents a healthcare strategy that customizes prevention, diagnosis, and treatment based on an individual’s genetic makeup, environmental influences, and lifestyle choices. The rise of personalized medicine stems from genomic advancements, which facilitate a more profound comprehension of unique genetic variations. This, in turn, allows for more accurate, targeted therapies, leading to better patient results and minimizing experimental treatment approaches. Cardiogenomics contributes to personalized medicine through the application of genetic understanding to adapt the prevention, diagnosis, and treatment of cardiovascular diseases to an individual’s specific genetic characteristics. For example, in February 2024, data from the US-based non-profit Personalized Medicine Coalition revealed that the FDA sanctioned 16 new personalized treatments for rare disease patients in 2023, a significant increase from six in 2022. Additionally, the personalized treatments approved in 2023 encompassed seven cancer drugs and three for various other conditions. Consequently, the expanding demand for personalized medicine is fueling the growth within the cardiogenomics market.

What Are The Different Segment Classifications Within The Cardiogenomics Market?

The cardiogenomics market covered in this report is segmented as

1) By Product Type: Testing Kits, Reagents, Instruments, Software, Services

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies

3) By Application: Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, OtherApplications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users

Subsegments:

1) By Testing Kits: PCR (Polymerase Chain Reaction) kits, Microarray kits, NGS (Next Generation Sequencing) kits

2) By Reagents: Enzymes, Probes, Buffers

3) By Instruments: Sequencers, Genotyping instruments, Microarray scanners

4) By Software: Data analysis software, Reporting platforms, Bioinformatics tools

5) By Services: Genetic testing services, Counseling services, Data analysis services

What Trends Are Redefining The Cardiogenomics Market Dynamics?

Leading companies within the cardiogenomics market are concentrating on developing innovative solutions, such as oncogenomics, to improve the early detection and personalized treatment of cardiovascular-related cancers. Oncogenomics refers to the study of cancer-related genes and their mutations to comprehend cancer development and progression, and to formulate targeted therapies and personalized treatment approaches. For instance, in April 2025, Fortis Healthcare Ltd., an India-based healthcare company, launched a Fortis Institute of Genomic Medicine in India to advance genetic research and personalized medicine. This initiative transforms patient care by enabling early disease detection, precise diagnosis, and personalized treatment across specialties like oncology, cardiology, and neurology. It empowers targeted therapies, improves treatment outcomes, and supports preventive care for hereditary conditions. The institute’s purpose is to advance precision medicine through a multidisciplinary team and innovative technologies, making healthcare more personalized and effective for Indian patients.

Which Key Players Are Driving Competition In The Cardiogenomics Market?

Major companies operating in the cardiogenomics market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report

What Are The Key Regional Factors Influencing The Cardiogenomics Market Growth?

North America was the largest region in the cardiogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Cardiogenomics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28156&type=smp

Browse Through More Reports Similar to the Global Cardiogenomics Market 2025, By The Business Research Company

Non Opioid Pain Patch Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report

Topical Pain Relief Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/topical-pain-relief-global-market-report

Pain Patch Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-patch-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795